TLR7 and renal cell carcinoma: These findings corroborate our previous demonstration of biologic efficacy against disseminated RCC cells and warrant further investigation to determine whether TLR7 activation may have clinical utility in therapeutically targeting both the primary tumor and systemic disease in RCC patients.